Ropivacaine Inhibits Lung Cancer Cell Malignancy Through Downregulation of Cellular Signaling Including HIF-1α In Vitro

• Auteurs principaux: Junmei Shen (Auteur), Lina Han (Auteur), Yongxian Xue (Auteur), Chao Li (Auteur), Huiqun Jia (Auteur), Kangsheng Zhu (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Background: Ropivacaine is widely used to induce regional anesthesia during lung cancer surgery. Previous studies reported that amide-linked local anesthetics, e.g., ropivacaine, affected the biological behavior of lung adenocarcinoma cells, but the conclusion is controversial and warrants further s...